| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() |
order@pharm-intermediates.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Selleck Chemicals LLC | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (713) 535-9129 | |||
![]() |
info@selleckchem.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2014 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8992-5085 | |||
![]() |
sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2015 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (831) 457-3800 | |||
![]() |
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| VDM Biochemicals | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (330) 252-8181 | |||
![]() |
sales@vdmbio.com info@vdmbio.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Inhibitor >> PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) >> GSK-3 inhibitor |
|---|---|
| Name | N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea |
| Synonyms | AR 0133418; AR 014418; AR-AO 14418; GSK 3B Inhibitor VIII; GSK 3beta inhibitor VIII |
| Molecular Structure | ![]() |
| Molecular Formula | C12H12N4O4S |
| Molecular Weight | 308.31 |
| CAS Registry Number | 487021-52-3 |
| EC Number | 637-170-6 |
| Solubility | Insoluble (8.3E-3 g/L) (25 ºC), Calc.* |
|---|---|
| Density | 1.464±0.06 g/cm3 (20 ºC 760 Torr), Calc.* |
| Melting point | 211-213 ºC** |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs) |
| ** | Lo Monte, Fabio; Bioorganic & Medicinal Chemistry Letters 2011, V21(18), P5610-5615. |
| Hazard Symbols |
Xn Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Codes | R22;R37/38;R41 Details | ||||||||||||||||||||||||
| Safety Description | S26;S36/39 Details | ||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea |